These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37305537)

  • 21. Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells.
    Wang X; Hui R; Chen Y; Wang W; Chen Y; Gong X; Jin J
    Front Pharmacol; 2020; 11():603491. PubMed ID: 33381044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrigendum: Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy.
    Zhou Y; Gao X; Yuan M; Yang B; He Q; Cao J
    Front Pharmacol; 2021; 12():785732. PubMed ID: 34744754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy.
    Bhagwat GS; Athawale RB; Gude RP; Md S; Alhakamy NA; Fahmy UA; Kesharwani P
    Front Pharmacol; 2022; 13():1123542. PubMed ID: 36712681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corrigendum: Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension.
    He YY; Xie XM; Zhang HD; Ye J; Gencer S; van der Vorst EPC; Döring Y; Weber C; Pang XB; Jing ZC; Yan Y; Han ZY
    Front Pharmacol; 2021; 12():810178. PubMed ID: 34975506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum: Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1) outcomes.
    Chen L; Sun H; Zhao R; Huang R; Pan H; Zuo Y; Zhang L; Xue Y; Song H; Li X
    Front Pharmacol; 2022; 13():1079635. PubMed ID: 36452221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrigendum: Paraptosis: a unique cell death mode for targeting cancer.
    Hanson S; Dharan A; V JP; Pal S; Nair BG; Kar R; Mishra N
    Front Pharmacol; 2023; 14():1274076. PubMed ID: 37745056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model.
    Morales-Cano D; Izquierdo-García JL; Barreira B; Esquivel-Ruiz S; Callejo M; Pandolfi R; Villa-Valverde P; Rodríguez I; Cogolludo A; Ruiz-Cabello J; Perez-Vizcaino F; Moreno L
    Front Pharmacol; 2023; 14():1228923. PubMed ID: 37377931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corrigendum: Docetaxel-loaded novel nano-platform for synergistic therapy of non-small cell lung cancer.
    Feng X; Xiong X; Ma S
    Front Pharmacol; 2022; 13():964540. PubMed ID: 36160393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corrigendum: Biochemical Pathways Triggered by Antipsychotics in Human Oligodendrocytes: Potential of Discovering New Treatment Targets.
    Brandão-Teles C; de Almeida V; Cassoli JS; Martins-de-Souza D
    Front Pharmacol; 2019; 10():344. PubMed ID: 31024311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics.
    Bartmann L; Schumacher D; von Stillfried S; Sternkopf M; Alampour-Rajabi S; van Zandvoort MAMJ; Kiessling F; Wu Z
    Front Pharmacol; 2020; 11():617329. PubMed ID: 33324229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corrigendum: Unravelling the therapeutic potential of botanicals against chronic obstructive pulmonary disease (COPD): molecular insights and future perspectives.
    Mitra S; Anand U; Ghorai M; Vellingiri B; Jha NK; Behl T; Kumar M; Radha ; Shekhawat MS; Proćków J; Dey A
    Front Pharmacol; 2024; 15():1365790. PubMed ID: 38515842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel involvement of miR-522-3p in high-mobility group box 1-induced prostaglandin reductase 1 expression and reduction of phagocytosis.
    Kang GJ; Lee HJ; Byun HJ; Kim EJ; Kim HJ; Park MK; Lee CH
    Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):625-633. PubMed ID: 28088550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corrigendum: 7-Ethyl-10-Hydroxycamptothecin, A DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth.
    Wang A; Li L; Li M; Wang S; Wang C
    Front Pharmacol; 2021; 12():757060. PubMed ID: 34526906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corrigendum: Editorial: Serotonin and Memory.
    Meneses A; Gasbarri A
    Front Pharmacol; 2016; 7():36. PubMed ID: 26903871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corrigendum: Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib.
    Shaker ME; Gomaa HAM; Hazem SH; Abdelgawad MA; El-Mesery M; Shaaban AA
    Front Pharmacol; 2023; 14():1281416. PubMed ID: 37745058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrigendum: R-carvedilol, a potential new therapy for Alzheimer's disease.
    Yao J; Chen SRW
    Front Pharmacol; 2022; 13():1125890. PubMed ID: 36712655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corrigendum: Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis.
    Zheng F; Wang Y; Zhang Q; Chen Q; Liang CL; Liu H; Qiu F; Chen Y; Huang H; Lu W; Dai Z
    Front Pharmacol; 2023; 14():1201715. PubMed ID: 37205909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis
    Zhai T; Zhang X; Hei Z; Jin L; Han C; Ko AT; Yu X; Wang J
    Front Pharmacol; 2021; 12():792330. PubMed ID: 34744756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corrigendum: Therapy by physician-pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis.
    Lu X; Zhang L; Huang H; Wu X; Wang Z; Huang L; Li J; Yu H; Zhang H; Xiao J
    Front Pharmacol; 2023; 14():1327256. PubMed ID: 38044935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Expression of PTGR1 Promotes NSCLC Cell Growth via Positive Regulation of Cyclin-Dependent Protein Kinase Complex.
    Huang X; Zhou W; Zhang Y; Liu Y
    Biomed Res Int; 2016; 2016():5230642. PubMed ID: 27429979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.